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Background: Plasminogen (Pg), the precursor of the proteolytic and fibrinolytic enzyme of blood, is converted to
the active enzyme plasmin (Pm) by different plasminogen activators (tissue plasminogen activators and urokinase),
including the bacterial activators streptokinase and staphylokinase, which activate Pg to Pm and thus are used
clinically for thrombolysis. The identification of Pg-activators is therefore an important step in understanding their
functional mechanism and derives new therapies.
Methods: In this study, different computational methods for predicting plasminogen activator peptide sequences
with high accuracy were investigated, including support vector machines (SVM) based on amino acid (AC),
dipeptide composition (DC), PSSM profile and Hybrid methods used to predict different Pg-activators from both
prokaryotic and eukaryotic origins.
Results: Overall maximum accuracy, evaluated using the five-fold cross validation technique, was 88.37%, 84.32%,
87.61%, 85.63% in 0.87, 0.83,0.86 and 0.85 MCC with amino (AC) or dipeptide composition (DC), PSSM profile and
Hybrid methods respectively. Through this study, we have found that the different subfamilies of Pg-activators are
quite closely correlated in terms of amino, dipeptide, PSSM and Hybrid compositions. Therefore, our prediction
results show that plasminogen activators are predictable with a high accuracy from their primary sequence.
Prediction performance was also cross-checked by confusion matrix and ROC (Receiver operating characteristics)
analysis. A web server to facilitate the prediction of Pg-activators from primary sequence data was implemented.
Conclusion: The results show that dipeptide, PSSM profile, and Hybrid based methods perform better than single
amino acid composition (AC). Furthermore, we also have developed a web server, which predicts the Pg-activators
and their classification (available online at http://mamsap.it.deakin.edu.au/plas_pred/home.html). Our experimental
results show that our approaches are faster and achieve generally a good prediction performance.
Keywords: Pg-activators, Plasminogen activators, Streptokinase, Staphylokinase, Urokinase, Tissue plasminogen
activators, SAK, SK, UK, tPA, Comparative analysis, SVM, Support vector machineBackground
Plasminogen activators are serine proteases which convert
plasminogen to plasmin, thus promoting fibrinolysis. The
identification of Pg-activators is very important due to their
function in blood clot formation. The fibrinolytic system
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article, unless otherwise stated.system, controls not only the intravascular fibrin deposition,
but also participates in a wide variety of physiologic and
pathologic processes. The Pg-activators cleave plasminogen
to produce two chains of active plasmin by a single proteo-
lytic cleavage of the Arg560-Val562 peptide bond [1]. Plas-
min is responsible for the degradation of blood clots.
Broadly, the Pg-activators are classified into two types based
on their mechanism of function; direct and indirect activa-
tors. Pg-activators such as tissue plasminogen activator
(tPA), widely found in tissues, and urokinase (UK), origin-
ally identified in urine, are classified into direct or multipleCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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to convert plasminogen to active plasmin by cleaving the
Arg-Val bond on the single-chain plasminogen to release
two plasmin chains. UK is a 411 residue protein, consisting
of three domains and is activated by proteolytic cleavage
between L158 and I159 [2,3]. In contrast, Pg-activators
of bacterial origins, such as Streptokinase (SK) and
Staphylokinase (SAK), are often indirect activators [4-6].
Usually, indirect Pg-activators serve as co–factors of plas-
minogen, forming an active 1:1 stoichiometric complex
with plasminogen/plasmin that degrades fibrin clots [7].
SK is a single chain polypeptide made up of 414 amino
acid residue and has a molar mass of 47 kDa. SK by itself
is not a plasminogen activator, but it binds with free circu-
lating plasminogen to form a complex (1:1), which can
convert additional plasminogen to plasmin. Similarly, bac-
terial SAK, consists of a single polypeptide chain of 136
amino acids. The SAK–plasminogen complex is however
inactive, until it is converted to an active SAK-plasmin
complex by other Pg-activators [8,9]. The Pg-activators of
eukaryotic origin UK and tPA are trypsin like serine
protease that activate plasminogen directly and are non-
immunogenic. By contrast, bacterial pg-activators are
generally indirect plasminogen activators which pro-
duce systemic fibrinolysis. tPA and SK are widely used
thrombolytic agents for therapy. As tPA is a eukaryotic
protein, it is difficult and costly to produce, but SK and
SAK can be easily produced. However, it is widely ac-
cepted that these two therapeutic molecules suffer from
serious complications such as immunogenicity (in SK),
brain hemorrhage (SK as well tPA) and unwanted bleed-
ing episodes. Therefore, identifying novel molecules
which are really good therapeutics without complica-
tions is a desired but challenging task. This may require
extensive bacterial screening or the development of
other methods to search for new molecules. Neverthe-
less, there is a need to improve the efficacy of these Pg-
activators and also a need to identify novel Pg-activators
with more favorable Pg-activation characteristics.
With the escalation of prokaryotic genome sequen-
cing, there is an ever-increasing need for prediction tools
and databases to characterize and present data relating
to particular gene functions. The large number of hypothet-
ical protein sequences available demands user-friendly
computational tools to facilitate various functional genomic
analyses. There are many statistical, similarity and evolu-
tionary analysis available for protein and DNA [10-12] and,
various prediction databases are available [13]. However, to
our knowledge, no prediction tools are currently available
to predict Pg-activators from protein sequences. According
to the NCBI database, 82 genome, 2003 genes and 6200
proteins have been identified as plasminogen activator
related sequence sources. With the sequencing of an in-
creasing number of genomes, a large number of novelPg-activator may remain to be discovered. For example, be-
side bacterial peptides, pg-activators have been identified in
snake venom and Vampire bat saliva [14,15].
Therefore, we have made a systematic attempt to de-
velop a method for recognizing Pg-activators and their
subfamilies. We have designed a method, which is able
to recognize the four subfamilies of SAK, SK, tPA and
UK. The classification and assignment of pg-activators
to various subfamilies was done on the basis of amino
(AC), dipeptide composition (DC), PSSM profile and
Hybrid approach using a machine learning based sup-
port vector Machine (SVM) methodology. The SVM
based predictive approach is widely used to handle large
data and it has been shown to perform well in multiple
areas of biological data analysis, including classification,
protein functions and type identification [16]. In this
study, we have implemented SVM classifiers and used
five-fold cross validation to evaluate the performance of
all classifiers. For this, the dataset was randomly parti-
tioned into five equal sets and evaluated five times with
each distinct set used as input and the remaining four
sets used for training. Our prediction tool can directly
predict Pg-activator and their classification. Apart from
this prediction study, a tool should provide additional
basic information on input sequences. For this, we have
also implemented programs to calculate the molecular
weight, amino acid residues calculation and percentage
of amino acid composition. Therefore, this tool will
serve not only for prediction but also to know the basic
properties of input sequences.
Results
Amino acid composition analysis
When the amino acid composition of Pg-activators se-
quences were compared to non-Pg-activators proteins, it
was observed that certain types of residues are (e.g., Lys,
Trp and Tyr) are present at significantly higher frequencies
in Pg-activators (Figure 1). As shown in Figure 2, Cys and
Trp are less common in Pg-activators (SK and SAK) of pro-
karyotic origin compared to eukaryotic Pg-activators. Inter-
estingly, Ala, Gly, Argis comparatively higher in eukayotic
Pg-activators (tPA and UK).
Amino acid composition SVM modules
Pg-activator prediction models were first developed using
amino acid composition of the Pg-activators through sup-
port vector machines (SVM). SVM was trained on the
different data sets using the SVM_light [17,18] implementa-
tion. First, SVM classifiers were developed using an amino
acid composition vector of 20 dimensions. SVM Kernels
and parameters were optimized for the best discrimination
between positive and negative protein sequence data sets.
Amino acid composition based prediction of Pg- activators
(SK, SAK, UK and tPA) against non Pg-activators resulted
Figure 1 The percentage of average amino acid composition of Pg vs non Pg-activators (X-axis: amino acid residues and Y-axis:
number of amino acid in percentage).
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0.87 sensitivity, specificity and Mathew correlation coeffi-
cient (MCC) respectively. Finally, individual Pg-activator
sub-class (SAK, SK, tPA and UK) predictions, where one
sub-class of Pg- activators were considered as positive and
all other sub-class activators taken as negative for SVM
training [19,20] resulted in accuracy of 96.06%, 95.77%,
95.83%, 90.68% with 0.93, 0.95, 0.97, 0.93 of MCC for SAK,
SK, tPA and UK subfamilies respectively (Table 1).
SVM modules using dipeptide composition
Dipeptide composition based SVM methods are gener-
ally more successful than single amino acid compos-
ition method. Here, SVM_classifiers have also beenFigure 2 Amino acid composition comparisons of four types of Pg-ac
minimum number of residues (X-axis: amino acid residues and Y-axisdeveloped on dipeptide composition represented by a
400 dimension of vector (20 × 20) of dipeptide fre-
quencies. During the optimization of kernel parameter
γ and trade-off parameter C, better prediction per-
formance as obtained with γ = 3 and C = 375. Based
on these parameters, we have developed models to
discriminate Pg-activators from non-Pg-activators se-
quences. As shown in Table 1, the SVM based model
was able to achieve a maximum accuracy of 84.32% to
97.01%, 75.31% sensitivity, specificity and 0.83 MCC.
Further classification models for sub-classification of
pg-activators have been developed and resulted in ac-
curacy of 86.82%, 86.40%, 92.70%, 87.03% of SAK, SK,
tPA and UK respectively, which was shown in Table 2.tivators (SAK, SK, tPA and UK), arranged as maximum to
: the number of amino acid in percentage).
Table 1 The performance of various SVM models of Pg-
activators (SAK, SK, tPA and UK) with non Pg- activators,
was developed using AC, DC,PSSM profiles and Hybrid
models in five-fold cross validation
ACC(%) SN(%) SP(%) MCC Parameters
Methods γ C
AC 88.37 95.24 83.50 0.87 25 450
DC 84.32 97.01 75.31 0.83 3 375
PSSM 87.61 95.77 81.81 0.86 3 400
Hybrid (AC + DC) 85.63 97.71 77.06 0.85 1 450
AC- Amino acid composition, DC dipeptide composition, PSSM position specific
scoring matrix, ACC accuracy, SN- Sensitivity, SP- specificity, MCC- Mathews
correlation coefficient,C: tradeoff value, γ- gamma factor (a parameter in
RBF kernel).
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A hybrid prediction method combining amino acid com-
position (AC) and dipeptide composition (DC) was also
attempted to solve the Pg-activator protein prediction prob-
lem [21]. Using the hybrid approach, accuracy, sensitivity,
specificity and MCC were 85.63%, 97.71%, 77.06%, and 0.85
respectively (Table 1). A comparison of the performance of
various Pg-activators classifiers is shown in Table 2. For the
hybrid model, the accuracy was 87.29%, 89.33%, 83.63%,Table 2 The performance of various SVM models was
developed using AC, DC, PSSM profiles and Hybrid
methods on the individual Pg-activators SAK, SK, UK and
tPA in five-fold cross validation
Proteins Methods ACC(%) SN(%) SP(%) MCC Parameters
γ C
SAK AC 96.06 92.30 96.91 0.93 3 300
DC 86.82 87.08 86.76 0.83 3 75
PSSM 93.98 92.28 94.34 0.92 1 300
Hybrid 91.72 96.63 90.62 0.93 1 150
SK AC 95.77 99.05 92.92 0.95 3 275
DC 86.40 93.12 80.56 0.82 10 25
PSSM 97.10 100 94.44 0.97 1 400
Hybrid 90.75 99.05 83.55 0.90 1 250
tPA AC 95.83 100 95.71 0.97 50 100
DC 92.70 70.58 93.35 0.78 15 450
PSSM 97.73 100 97.67 0.98 4 200
Hybrid 92.69 75.00 93.20 0.81 10 450
UK AC 90.68 100 86.77 0.93 3 300
DC 87.03 95.03 83.66 0.87 15 500
PSSM 92.06 93.19 91.56 0.90 5 9
Hybrid 85.03 99.40 79.00 0.88 1 450
AC- Amino acid composition, DC dipeptide composition, PSSM position
specific scoring matrix, ACC accuracy, SN- Sensitivity, SP- specificity,
MCC- Mathews correlation coefficient,C: tradeoff value, γ- gamma factor
(a parameter in RBF kernel).
SAK - Staphylokinase, SK - Streptokinase, tPA - tissue plasminogen activators,
UK - Urokinase.and 84.48% for SAK, SK, tPA and UK respectively. In
general the results of the hybrid compared to the indi-
vidual models show an increase in sensitivity at the
cost of a decrease in specificity, providing marginal im-
provement overall.
PSSM profile based SVM modules
In order to improve the performance of SVM models,
position specific score matrix (PSSM) profile based predic-
tion models for Pg-activators were also developed and
achieved a maximum accuracy of 87.61% with 95.77%,
81.81% sensitivity, specificity and 0.86 of MCC (Table 1).
The parameters were subsequently optimized for predict-
ing Pg-activators subclass and achieved a maximum ac-
curacy of 93.98%, 97.10%, 97.73%, 92.06% with MCC of
0.92, 0.97, 0.98, 0.90 for SAK, SK, tPA and UK respect-
ively. In general all models performed comparatively well
as estimated by accuracy and MCC measures, including
the simple AC method (Table 2).
Prediction result analysis
SVM- prediction results obtained with optimized kernel
parameters on known Pg-act peptides are shown in
Additional file 1 a,b,c for SK, Additional file 2-a,b,c for
SAK, Additional file 3-a,b,c for UK and Additional file 4
for tPA of amino acid(AC), dipeptide(DC) and PSSM
profiles composition respectively. It can be seen that a
large number of activators are predicted over a threshold
of 0.9 and all are predicted above threshold 0.5.
Prediction scoring graphs and confusion matrix analysis
The performance of SVM modules was also checked by
examination of the confusion matrix and scoring graphs.
The scoring graph represents the score of the prediction
for all individual sequences tested (indexed on the hori-
zontal axes), showing how the score of sequences in the
positive set (left side of the graph) is separated from the
negative set (right side) by a threshold (typically set to
zero) that can be used to classify positive and negative
predictions. However, not all positive or negative sequences
may be correctly classified, leading to false negative and
false positive prediction outcomes. To represent this aspect
of the performance, the confusion matrix summarizes the
outcomes of the prediction (Table 3) [22]. The analysis
shows that only two Pg-activator sequences are negatively
predicted in the PSSM model while amino, dipeptide and
Hybrid models predicted all sequences in the test set cor-
rectly (Figures 3 and 4). In subfamilies classification, all sub-
classes were predicted correctly. The only misclassification
was that tPA sequences were also often positively predicted
by UK models and, conversely, UK sequences were some-
times positively predicted by tPA classifiers. This observa-
tion suggests some overlap between UK and tPA sequence
composition. More interestingly, there is no confusion in
Table 3 Confusion matrix of all Pg-act proteins (SAK, SK, tPA and UK) against the SVM best models (implemented in
the Pg-act server)
Total SAK SK tPA UK
Methods AC DC PSSM Hybrid AC DC PSSM Hybrid AC DC PSSM Hybrid AC DC PSSM Hybrid
SAK 69 69 69 69 69 0 0 0 0 0 0 0 0 0 0 0 0
SK 167 0 0 0 0 167 167 167 167 0 0 0 0 0 0 0 0
tPA 11 0 0 0 0 0 0 0 0 5 11 11 10 6 0 0 1
UK 109 0 0 0 0 0 0 0 0 0 2 2 2 109 107 107 107
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sponding models. The false positive rate (FPR) estimated
on the negative dataset was 0.17, 0.25 and 0.18 in AC, DC
and PSSM profile respectively.
ROC-Plot (receiver operating characteristic plot)
In order to confirm the performance of our models, we
plotted the sensitivity versus 1-specificity chart, also
known as receiver operating curve (ROC) [23]. It is aFigure 3 Prediction scores graph of all Pg-activators Vs non Pg-activa
which implemented in our online server. A). AC - method, B). DC - method
DC methods). (X-axis is indexed on Pg-activators and Y-axis is the predictiotwo-dimensional depiction of classifier performance
[24,25]. The area under the curve for Pg-activators for
amino, dipeptide, PSSM and Hybrid was 0.980, 0.974,
0.977, 0.975 respectively. In the classification of Pg acti-
vators, we achieved AUC of 0.986 0.996, 0.975, 0.996 for
SAK, 0.991, 0.998, 0.982, 0.998 for SK, 0.886, 0.899,
0.898, 0.906 for tPA, 0.962, 0.989, 0.973, 0.977 for UK
with the amino, dipeptide, PSSM and Hybrid methods
respectively (Figure 5).tors. The prediction scores graph was generated by the best model
C). PSSM - method and D). Hybrid - method (combination of AC and
n score).
Figure 4 Prediction scores graph for Sub-class Pg-activators. The best model of SAK, SK, tPA and UK was used to generate the prediction
scores graph which used in online-server. A). AC - Method of SAK, SK, tPA and UK Pg-activators, B). DC - method of SAK, SK, tPA and UK Pg-
activators C). PSSM - method of SAK, SK, tPA and UK Pg-activators and D). Hybrid – method (combination of AC and DC methods) of SAK, SK, tPA
and UK Pg-activators. (X-axis is indexed on Pg-activators of (SAK, SK, tPA and UK in respective order) and Y- axis is the score of the prediction).
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In order to assess further if the classifier is able to pre-
dict Pg-activators not included in the original dataset
used for training, new pg-activator sequences were re-
trieved from the latest versions of the Uniprot/Swissprot
database, and tested in the pg-activator prediction ser-
ver. A total of 207 new sequences previously unseen by
the SVM algorithm were obtained (Additional file 5). All
these sequences were correctly predicted as positive by
all pg-activator models (AC, DC, PSSM and Hybrid
models). Interestingly, this included vampire bat saliva
and Snake Venom pg-activators, further supporting the
efficacy of positive prediction on novel sequences.
Web server
A freely accessible web server has been developed using
simple html format, cgi-Perl programs and the optimizedSVM algorithm for prediction of Pg-activators sequences.
Firstly, our program predicts whether the input sequence is
a pg-activators or not. Secondly, if the answer is positive,
the sequence is assigned to the most likely Pg-activators
subclass. The input sequence can be any format and our
program allow user to make prediction with different pre-
diction accuracy thresholds.
Discussion
At present, a large number of methods have been devel-
oped to predict the function of proteins. Most of these
methods have been developed for protein structure pre-
diction, subcellular localization and functional classifi-
cation of proteins [26-28]. In this study, we have made
a systematic attempt to predict Pg-activator proteins
and their sub-classes through SVM. Streptokinase is a
414 amino-acid peptide secreted by many β-hemolytic
Figure 5 ROC- plot: The performance of SVM models for all Pg-activators developed using all methods. A). Pg-activators in all methods
(AC, DC, PSSM and Hybrid). B). SAK Pg-activators in AC, DC, PSSM and Hybrid methods. C). SK Pg-activators in AC, DC, PSSM and Hybrid methods.
D). tPA Pg-activators in AC, DC, PSSM and Hybrid methods. E). UK Pg-activators in AC, DC, PSSM and Hybrid methods.
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three domains (residues 1–150), β (residues 151–287),
and γ (residues 288–414). Unlike urokinase (UK) and tPA
that cleave the plasminogen bond Arg561-Val562 to gener-
ate plasmin, Streptokinase (SK) lacks intrinsic protease ac-
tivity. Instead, SK forms a stoichiometric complex with Pg
and coverts it to an activator complex. Staphylokinase is a
single domain protein of 136 amino acids. It also like SK,
forms a stoichiometric complex with plasminogen and the
SK + Pg complex then activates plasminogen.
All Pg-activators can activate Pg but they have differ-
ent mechanisms of action and specificity. Here, through
a comprehensive approach we used amino acid, dipetide
composition, PSSM profile and Hybrid methods to pre-
dict the putative Pg activation abilities of novel protein
sequences. However, the approach is purely based on se-
quence composition and this does not explain any mechan-
istic details of Pg activation. So identifying and predicting
the amino acid sequence which are related to differential
mechanism and different specificity may need more rigor-
ous computational as well as experimental methods. How-
ever, the results show that good predictions can beobtained from sequence composition alone, suggesting
that certain features of sequence allow the useful discrim-
ination of Pg-activators. However, SVM does not easily
permit the direct identification of the feature having the
most influence in any details, and this aspect will need to
be explored further.
The PgActPred server can predict Pg-activators as well
as in their SAK, SK, tPA or UK sub-class with high ac-
curacy, sensitivity, specificity and MCC. In general, di-
peptide (DC) and PSSM models predict better than the
simple amino acid composition models (AC).
Conclusion
In this study, for the first time, a method has been devel-
oped for the prediction of Pg-activators and their sub-
classification in subfamilies such as Streptokinase (SK),
Staphylokinase (SAK), tissue plasminogen activators (tPA)
and Urokinase (UK) from their amino acid sequence alone.
It has been observed that all methods implemented are
comparable predictors, including the simple amino acid
composition model. A confusion matrix has been produced
to cross check the predicted results, showing all prokaryotic
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few eukaryotic Pg-activators are misclassified. Remark-
ably, Cysteine (C) residues are absent in all prokaryotic
Pg-activators. Tremendous amount of lysine (K) is present
in prokaryotic Pg-activators, so this residue may play im-
portant contributions to indirect plasminogen activators.
Pg-activators perform a unique function even though they
come from different origins and our study and tools facili-
tate the annotation of pg-activators.
Methods
Datasets
The data of all Pg-activators were extracted from Uniprot/
SWISSPROT database. The data set was created by remov-
ing sequences annotated as “fragments”, “isoforms”, “poten-
tials”, “similarity”, or “probables”. This dataset was further
processed with the CD-hit program to remove sequences
with more than 90% similarity with any other in the dataset
to avoid redundancy and incorporation of variants [29].
The final dataset contains 356 Pg-activators (positive data-
set). The negative dataset consisted of 501 non Pg-activator
sequences randomly selected out of 19534 regulatory
proteins. The Pg-activators containing 69 Staphylokinase
(SAK), 167 streptokinase (SK), 11 tissue plasminogen
activator (tPA), and 109 of urokinase (UK) sub-family
sequences respectively. The negative sequence set was
selected by the general keyword query for “regulatory
proteins” in Uniprot/Swisprot (regulatory proteins from
various species).
Amino acid and dipeptide composition
The amino acid composition is the fraction of each amino
acid in a protein. The SVM_light requires the encoding of
data into vectors. So the fraction of all 20 natural amino
acids was calculated using the following equation:
Fraction of amino acid ið Þ
¼ Total number of amino acid ið Þ
Total number of amino acids in protein
ð1Þ
Where (i) can be any amino acid.
Similarly, dipeptide composition has been calculated
by a vector having a fixed length of 400 (20 × 20) dimen-
sions. The fraction of each dipeptide composition was
calculated by the following equation:
Fraction of dipeptide ið Þ
¼ Total number of dipep ið Þ
Total number of all possible dipeptides
ð2Þ
PSSM profile
PSSM profile was generated using the GPSR package
against nr (non redundant) blast database. In gpsr packagewe have used seq2pssm_imp, pssm_n2, pssm_comp and
col2svm programs for PSI-BLAST searches against the nr
database using different iterations with a cutoff e-value
0.001, and to normalize the PSSM profile and generate the
SVM_light input format (i.e. as a composition vector of
400) [30]. Finally, the SVM models were generated using
different parameters, optimized and, the best model used in
the prediction server.
Evaluation and performance
A five-fold cross validation technique has been used to
evaluate performance. Firstly we used Pg-activators as
positive dataset and non Pg-activators as negative data-
set. Both positive and negative datasets were randomly
divided into five equal sets. To run SVM, four sets were
used for training and the remaining set for testing. This
process was repeated five times, so that each sub-set was
used once for testing. This has been applied to all
methods i.e. amino acid, dipeptide, PSSM and Hybrid
predictions of Pg-activators. The final performance was
calculated by average the results of testing on all five
sets. The sensitivity, specificity, accuracy and Mathew
correlation coefficient (MCC), were adopted for per-
formance evaluation of the classifiers. These measures
were calculated with the following standard formulas;
Accuracy ¼ TPþ TN





MCC ¼ TP TN−FP FNﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPþ FPð Þ TPþ FNð Þ TNþ FPð Þ TNþ FNð Þp
ð6Þ
Where TP, FP, TN and FN represent the number of
true positive, false positive, true negative and false nega-
tives respectively.
Support vector machine
The SVM_light, a highly successful machine learning
technique, has been used for the prediction of plasmino-
gen activators. The SVM can use various parameter set-
tings like kernel, linear, polynomial and radial basic
functions (RBI). In the prediction studies, we have opti-
mized different parameter for each prediction method.
In the first approach all Pg-activators were used as a
positive and the non Pg-activators as negative examples.
The same approach was also applied for classification in
one sub-class of Pg-activators using all other sub-classes
sequences as a negative example. In practice, we applied
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negative sequence to run SVM light.Additional files
Additional file 1: The streptokinase (SK) SVM best models
predicted all streptokinase (SK) proteins and sorted from Minimum
scores to maximum scores corresponding to their protein ID
(Uniprot/Swiss prot). The models of AC, DC and PSSM of 1a, 1b and
1crespectively. The construction of min to max score tables shows to
easily to identify the unknown and new SK proteins according to their
predicted scores.
Additional file 2: The all staphylokinase (SAK) proteins predicted by
all best models of AC, DC and PSSM, the scores sorted by the
minimum to maximum according to their protein ID (Uniprot/Swiss
prot) as 2a, 2b and 2c respectively. Using this table, the unknown and
similar SAK proteins easily can identify by using the predicted scores.
Additional file 3: The urokinase (UK) proteins of all predicted by
their best models of AC, DC and PSSM, the predicted scores sorted
as minimum to the maximum according to their protein ID
(Uniprot/Swiss prot) as 3a, 3b and 3c respectively. The unknown and
similar UK proteins can easily identify using the predicted scores.
Additional file 4: The tissue plasminogen activators (tPA) models
such as AC, DC, and PSSM predicted all tPA proteins, the scores
sorted from minimum to maximum displayed according to their
Uniprot/Swiss prot protein ID. The new and unknown tPA proteins can
easily identify the similar proteins according to their predicted scores.
Additional file 5: The list of new and unknown of Pg-activator
sequences, which was not in our dataset, predicted as Pg-activators in
our all models (AC, DC, PSSM and Hybrid).Competing interests
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